Thymoquinone and Poloxin are slow-irreversible inhibitors to human Polo-like kinase 1 Polo-box domain

Yin Zhou, Chen Jianhua, Peter H. Rehse

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To provide a kinetic model(s) and reveal the mechanism of thymoquinone and Poloxin blocking an emerging anti-cancer target, human Polo-like kinase 1 (hPlk1) Polo-box domain (PBD). Methods: The binding kinetics was determined by using a fluorescence polarization based assay. The putative mechanism was examined with a competition test. Results: Thymoquinone follows a one-step binding with an association rate constant (k1) of 6.635×103 L·mol-1·min-1. Poloxin fit a two-step binding with a dissociation constant (Ki) of 118 μmol/L for the intermediate complex and its isomerization rate (k4) of 0.131 5 min-1 to form an irreversible adduct. No significant dissociation was observed for either ligand up to 13 h. The inhibitors responded insignificantly to the presence of Michael donors as hPlk1-PBD competitors. Conclusion: Thymoquinone and Poloxin are slow-tight ligands to the hPlk1-PBD with kinetic models distinct from each other. Michael addition as the mechanism is excluded.

Original languageEnglish (US)
Pages (from-to)136-142
Number of pages7
JournalJournal of Medical Colleges of PLA
Volume25
Issue number3
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Ligands
Fluorescence Polarization
poloxin
polo-like kinase 1
thymoquinone
Neoplasms

Keywords

  • Fluorescence polarization
  • Irreversible inhibitor
  • Kinetics
  • Polo-like kinase

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Thymoquinone and Poloxin are slow-irreversible inhibitors to human Polo-like kinase 1 Polo-box domain. / Zhou, Yin; Jianhua, Chen; Rehse, Peter H.

In: Journal of Medical Colleges of PLA, Vol. 25, No. 3, 06.2010, p. 136-142.

Research output: Contribution to journalArticle

@article{b3f89dce3b46481cbe8d16beb92529bd,
title = "Thymoquinone and Poloxin are slow-irreversible inhibitors to human Polo-like kinase 1 Polo-box domain",
abstract = "Objective: To provide a kinetic model(s) and reveal the mechanism of thymoquinone and Poloxin blocking an emerging anti-cancer target, human Polo-like kinase 1 (hPlk1) Polo-box domain (PBD). Methods: The binding kinetics was determined by using a fluorescence polarization based assay. The putative mechanism was examined with a competition test. Results: Thymoquinone follows a one-step binding with an association rate constant (k1) of 6.635×103 L·mol-1·min-1. Poloxin fit a two-step binding with a dissociation constant (Ki) of 118 μmol/L for the intermediate complex and its isomerization rate (k4) of 0.131 5 min-1 to form an irreversible adduct. No significant dissociation was observed for either ligand up to 13 h. The inhibitors responded insignificantly to the presence of Michael donors as hPlk1-PBD competitors. Conclusion: Thymoquinone and Poloxin are slow-tight ligands to the hPlk1-PBD with kinetic models distinct from each other. Michael addition as the mechanism is excluded.",
keywords = "Fluorescence polarization, Irreversible inhibitor, Kinetics, Polo-like kinase",
author = "Yin Zhou and Chen Jianhua and Rehse, {Peter H.}",
year = "2010",
month = "6",
doi = "10.1016/S1000-1948(10)60032-9",
language = "English (US)",
volume = "25",
pages = "136--142",
journal = "Journal of Medical Colleges of PLA",
issn = "1000-1948",
publisher = "Elsevier Limited",
number = "3",

}

TY - JOUR

T1 - Thymoquinone and Poloxin are slow-irreversible inhibitors to human Polo-like kinase 1 Polo-box domain

AU - Zhou, Yin

AU - Jianhua, Chen

AU - Rehse, Peter H.

PY - 2010/6

Y1 - 2010/6

N2 - Objective: To provide a kinetic model(s) and reveal the mechanism of thymoquinone and Poloxin blocking an emerging anti-cancer target, human Polo-like kinase 1 (hPlk1) Polo-box domain (PBD). Methods: The binding kinetics was determined by using a fluorescence polarization based assay. The putative mechanism was examined with a competition test. Results: Thymoquinone follows a one-step binding with an association rate constant (k1) of 6.635×103 L·mol-1·min-1. Poloxin fit a two-step binding with a dissociation constant (Ki) of 118 μmol/L for the intermediate complex and its isomerization rate (k4) of 0.131 5 min-1 to form an irreversible adduct. No significant dissociation was observed for either ligand up to 13 h. The inhibitors responded insignificantly to the presence of Michael donors as hPlk1-PBD competitors. Conclusion: Thymoquinone and Poloxin are slow-tight ligands to the hPlk1-PBD with kinetic models distinct from each other. Michael addition as the mechanism is excluded.

AB - Objective: To provide a kinetic model(s) and reveal the mechanism of thymoquinone and Poloxin blocking an emerging anti-cancer target, human Polo-like kinase 1 (hPlk1) Polo-box domain (PBD). Methods: The binding kinetics was determined by using a fluorescence polarization based assay. The putative mechanism was examined with a competition test. Results: Thymoquinone follows a one-step binding with an association rate constant (k1) of 6.635×103 L·mol-1·min-1. Poloxin fit a two-step binding with a dissociation constant (Ki) of 118 μmol/L for the intermediate complex and its isomerization rate (k4) of 0.131 5 min-1 to form an irreversible adduct. No significant dissociation was observed for either ligand up to 13 h. The inhibitors responded insignificantly to the presence of Michael donors as hPlk1-PBD competitors. Conclusion: Thymoquinone and Poloxin are slow-tight ligands to the hPlk1-PBD with kinetic models distinct from each other. Michael addition as the mechanism is excluded.

KW - Fluorescence polarization

KW - Irreversible inhibitor

KW - Kinetics

KW - Polo-like kinase

UR - http://www.scopus.com/inward/record.url?scp=77955040022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955040022&partnerID=8YFLogxK

U2 - 10.1016/S1000-1948(10)60032-9

DO - 10.1016/S1000-1948(10)60032-9

M3 - Article

AN - SCOPUS:77955040022

VL - 25

SP - 136

EP - 142

JO - Journal of Medical Colleges of PLA

JF - Journal of Medical Colleges of PLA

SN - 1000-1948

IS - 3

ER -